295 related articles for article (PubMed ID: 20954856)
1. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
Felician WA; Ghaly ES
Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of chlorpheniramine maleate release from hydrophilic swellable polymer systems.
Melendez M; Ghaly ES
P R Health Sci J; 1997 Sep; 16(3):259-63. PubMed ID: 9431564
[TBL] [Abstract][Full Text] [Related]
3. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
Chowdary KP; Kamalakara RG
Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
[TBL] [Abstract][Full Text] [Related]
5. Matrices of water-soluble drug using natural polymer and direct compression method.
Rosario NL; Ghaly ES
Drug Dev Ind Pharm; 2002 Sep; 28(8):975-88. PubMed ID: 12378966
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Formulation Excipients and Thermal Treatment on the Release Properties of Lisinopril Spheres and Tablets.
Amador Ríos Z; Ghaly ES
Biomed Res Int; 2015; 2015():423615. PubMed ID: 26185757
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
[TBL] [Abstract][Full Text] [Related]
8. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization using response surface methodology.
Arora G; Malik K; Singh I
Polim Med; 2011; 41(2):23-34. PubMed ID: 21866794
[TBL] [Abstract][Full Text] [Related]
10. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
Ghaly ES; Malavé MI; Rivera WJ; Martí A
P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
[TBL] [Abstract][Full Text] [Related]
12. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
Goole J; Vanderbist F; Amighi K
Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841
[TBL] [Abstract][Full Text] [Related]
15. Mechanical properties of excipients do not affect polymer matrix formation.
Chatterjee L; Rades T; Tucker IG
Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
[TBL] [Abstract][Full Text] [Related]
16. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.
Kumar CS; Reddy-Budideti KK; Battula SP; Ayyavala CS
Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275
[TBL] [Abstract][Full Text] [Related]
17. The use of micronized cellulose disintegrants as insoluble swellable matrices for sustained-release tablets.
Nakagami H; Nada M
Drug Des Deliv; 1991 Jul; 7(4):321-32. PubMed ID: 1930623
[TBL] [Abstract][Full Text] [Related]
18. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
Nerurkar J; Jun HW; Price JC; Park MO
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
[TBL] [Abstract][Full Text] [Related]
19. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
[TBL] [Abstract][Full Text] [Related]
20. A new deferiprone controlled release system obtained by ultrasound-assisted compression.
Aguilar-De-Leyva A; Gonçalves-Araujo T; Daza V; Caraballo I
Pharm Dev Technol; 2014 Sep; 19(6):728-34. PubMed ID: 23984972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
